The specifics of survival time for patients with nasopharyngeal cancer turned to liver vary from person to person. However, according to statistics, the 1-year overall survival rate is 54.8%, the 2-year overall survival rate is 14.6%, the median survival time is generally 10 months, and the 5-year overall survival rate is generally around 10%~15%. Nasopharyngeal carcinoma is a malignant tumor that occurs in the top and lateral walls of the nasopharyngeal cavity. The cause of the disease is still unclear, although it is generally believed to be related to EBV infection, genetic factors, chemical factors, and so on. Nasopharyngeal cancer often occurs in the nasopharynx at the back of the nasal cavity, which is usually easy to be overlooked because of its hidden location and lack of obvious symptoms in the early stage. More than 95% of nasopharyngeal carcinomas are low-differentiated carcinomas, highly malignant and prone to distant metastasis. Usually, 6%~15% of patients have already developed distant metastasis when they are first diagnosed, and the most common metastatic organs include bone, lung and liver. The most common metastatic organs are bone, lung and liver, etc. The prognosis of patients with nasopharyngeal carcinoma combined with liver metastasis is closely related to age, treatment and whether there are metastases in other organs. According to a study in China, the 1-year and 2-year overall survival rate of patients with nasopharyngeal carcinoma combined with liver metastasis is 54.8% and 14.6% respectively, and the median survival time is 10 months. The median survival time is 10 months. There are also studies that the 5-year overall survival rate after treatment is about 10%~15%. The prognosis of patients with nasopharyngeal carcinoma with liver metastasis is closely related to age and whether the treatment is timely. If nasopharyngeal cancer is combined with liver metastasis, it is recommended to go to regular hospitals to have doctors make appropriate treatment plan after comprehensive evaluation of the condition and actively cooperate with doctors to avoid delaying the condition.